Drugs cost too much. There is a better way to fund medical innovation

Drugs Medicine 2018 United Nations

UNICEF/Olivier Asselin In Côte d’Ivoire, a counsellor from UNICEF partner NGO Femme Active, instructs an adolescent boy, diagnosed with HIV in 2012, on how to take his antiretroviral (ARV) medication correctly.

This article is brought to you based on the strategic cooperation of The European Sting with the World Economic Forum.

Author: Rufus Pollock, Lead, iMed Project, and Founder and President of Open Knowledge

Drugs are expensive. Very expensive, and becoming ever more so, it seems. Prices for new medicines have been steadily rising for the past few decades. It costs a great deal to bring new drugs to market, the explanation goes, and without high prices, the pipeline of new medicines will run dry.

This argument is unsustainable, especially when even the world’s most developed economies and healthcare systems are struggling to afford vital medicines. To keep paying more for drugs simply cannot be the answer. Bad health affects everyone. We should be urgently seeking new mechanisms of funding medical innovation that do not compromise on access.

There is a strong moral and social obligation for exploring alternatives. Millions of people globally do not have access to the medicines they need to survive. In the US, millions of adults skip prescribed medications due to the high cost. The same is true in Canada, where the public healthcare system does not usually extend to cover prescription medicines, and in Europe, especially in poorer members of the EU.

The situation is worse in less developed countries. Many pay out of pocket for drugs, and the hefty price tags can run many times the annual average income. Two widely used drugs for treating hepatitis C cost the equivalent of one or more years’ average earnings in 12 out of 30 countries, revealed a recent study by the World Health Organization. Millions are dying because they cannot afford the medicine they need to stay alive.

When some members of society lack medicine, there are consequences beyond the individual directly affected. The increased morbidity caused by a lack of access to medication places an extraordinary strain on healthcare systems, exacerbating the drain on their resources from ever more expensive drugs. In addition, unhealthy populations are far less economically productive than healthy ones. Beyond social justice, there are clear economic reasons to find new models of funding medical innovation that do not restrict access to medicine.

The current state of affairs is making the world a more dangerous place. Healthcare systems that are strained by increased morbidity, and by a critical lack of money and medicine, are less likely to be able to contain outbreaks when they occur. Poor global health increases global instability. Failing to ensure everyone has access to necessary medication can have profound knock-on consequences and worsen existing crises.

Moreover, the high sale price of drugs skews incentives for innovation towards wealthy consumers. This means that vital medicines for certain ailments are not accessible when needed on a global scale. For instance, the Ebola virus had been known about for decades before the recent outbreak, and yet virtually no treatments were available. The whole world is unprepared and at risk.

The explanation that pharmaceutical companies offer for high drug prices is compelling. It costs a great deal of money to bring a drug to market, they argue. This is why so many reluctantly accept the current state of affairs, in which innovation justifies restricted access. Though it is true that drugs do cost a lot to bring to market, there is a remarkable lack of consensus on exactly how much.

This is compounded by a systemic lack of transparency. It is often not known how much is spent on what, and how reliant private-sector developments are on publicly funded research. Often, medicines that are developed with significant help from public funds do not reflect that support in prices, and there is no guarantee under the monopoly rights patent system that they should.

Moreover, a great deal of money that could be earmarked for research is spent on marketing instead. Indeed, in some large drug companies, expenditure on marketing outweighs that on research.

This model is unsustainable. So long as we continue to reward innovation through a single channel – buying the drug – access to new medicines will be limited. Ultimately, the problem is about how we pay for medicine. Today, we only pay by purchasing the end product. This means that the costs of manufacture (which is cheap) and innovation (which is expensive) are rolled into one. This puts access and innovation in conflict.

If we were to change how we fund medicines, there could be no conflict. Incentives for innovation and access to affordable drugs could co-exist. We can fund research and production separately. There is no excuse for not exploring the wide systemic changes needed to make that happen.

Today’s model is unsustainable, unhealthy and utterly unnecessary. We can have new medicines and wide access to them. We should be working towards this as a matter of urgency.

And we have ideas. For example, at the iMed Project we’ve been developing innovative two-part payment models for funding medicines that would maintain incentives for innovators while making treatment at cost of manufacture.”

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

the European Sting Milestones

Featured Stings

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Here’s how data can shine a light on financial crime

The Schengen area is at a crossroads

These countries have some of the highest voter turnout in the world

Brexit: European Commission publishes Communication on preparing for the UK’s withdrawal from the EU

Towards a tobacco free India

Youth2030: UN chief launches bold new strategy for young people ‘to lead’

The MWC14 Sting Special Edition

What is hydroponics – and is it the future of farming?

First peaceful transfer of power in DR Congo ‘an extraordinary opportunity’ for advancing rights

UN forum spotlights cities, where struggle for sustainability ‘will be won or lost’

World Health Organisation and medical students: is there any room for improvement?

“France will be there, it will always be there!”, French President Hollande says in a rather disorganised speech; the Sting reports live from World Economic Forum 2015 in Davos

Is there a cure for corruption in Greece?

Fashion’s hot new trend: clothes you don’t need to wash (very often)

The EU Consumer Policy on the Digital Market: A Behavioral Economics View

Congolese expelled from Angola returning to ‘desperate situation’: UN refugee agency

What do the economic woes of Turkey, Argentina and Indonesia have in common?

Parliament wants to suspend EU accession negotiations with Turkey

Why Indian students are going abroad to become Doctors?

Office workers in these economies clock up the most extra hours

The Franco-German axis considers that all EU needs now is more armaments

Cancer is a growing global threat and prevention is key, UN study shows

How Hawaii plans to be the first US state to run entirely on clean energy

The secret weapon in the fight for sustainability? The humble barcode

Athens searches frantically for a new compromise between politics and economic reality

We need a fresh approach to climate change migration. This is why

‘Warp speed’ technology must be ‘force for good’ UN chief tells web leaders

Gaza probe finds ‘reasonable grounds’ Israeli forces committed international human rights violations

Report on EU trade defence – effective protection against unfair trade

EU job-search aid worth €9.9m for 1,858 former Air France workers

FROM THE FIELD: Survival in Yemen against all odds

Four million Syrian children have only known war since birth: UNICEF

MEPs list conditions for new EU-Azerbaijan deal

10 million Yemenis ‘one step away from famine’, UN food relief agency calls for ‘unhindered access’ to frontline regions

Paris, Washington, IMF against Berlin and ECB on money and interest

Future fit: 3 ways fashion can be more sustainable

FROM THE FIELD: Faces and Voices of Conflict

UN agencies welcome green light for Rohingya projects in northern Myanmar; urge ‘more effective access’

North Korean families facing deep ‘hunger crisis’ after worst harvest in 10 years, UN food assessment shows

Why capital markets have no more reservetions about Eurozone

SMEs and micro firms sinking together with south Eurozone

Innovation can transform the way we solve the world’s water challenges

UN says ‘many humanitarian achievements’, one year after ouster of ISIL from Mosul

The Brexit factor in the US-China trade war and other conflicts

‘Continuing absence’ of political solution to Israel-Palestine conflict ‘undermines and compounds’ UN efforts to end wholesale crisis

GSMA Announces Speakers for Mobile 360 – Russia & CIS 2018

The Brits are not an exception and that’s why they voted to leave

Fighting forest fires in Europe – how it works

European Semester 2018 Spring Package: Commission issues recommendations for Member States to achieve sustainable, inclusive and long-term growth

In Rome you can swap plastic bottles for metro tickets

EU Budget: A Reform Support Programme and an Investment Stabilisation Function to strengthen Europe’s Economic and Monetary Union

Fairness in the food supply chain: Commission proposes to increase price transparency

Meet Alice, the battery-powered plane that could herald the age of electric air travel

Eurozone slowly but surely builds its Banking Union

Ten reasons to be optimistic in 2019

Another doomed EU attempt to interfere in Libya?

Facebook/Cambridge Analytica: MEPs pursue personal data breaches probe

Inclusion, equality a must for ‘long-lasting peace and sustainable development’, UN official tells high-level event in Baku

Satellites and data are going to help us phase out fossil fuels. Here’s how

These are 2018’s stats of the year

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s